Literature DB >> 15522945

Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells.

Jung-Hye Choi1, Se-Hyung Park, Peter C K Leung, Kyung-Chul Choi.   

Abstract

Leptin, a secreted protein of the ob gene by white adipose tissue, plays an important role in the regulation of food intake and energy consumption in the brain and acts as a potential growth stimulator in normal and neoplastic breast cancer cells. However, a potential role of leptin as an endocrine regulator is unknown in ovarian cancer. In the present study, we investigated the expression of leptin receptors in immortalized ovarian surface epithelium (IOSE) and ovarian cancer cell lines, and potential effect of leptin on the cell growth and activation of mitogen-activated protein kinases (MAPKs) in the BG-1 ovarian cancer cell line. Both short and long isoforms of leptin receptors are expressed in IOSE-80PC (a post-crisis line), BG-1, OVCAR-3, and SKOV-3 cells. In addition, treatment with leptin resulted in the growth stimulation of BG-1 cells, an activation of ERK1/2 and inhibition of constitutive phosphorylation of p38 MAPK. These results suggest that further studies are necessary to validate whether leptin may be a potential regulator for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522945     DOI: 10.1210/jc.2004-0297

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  42 in total

1.  Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.

Authors:  Jim Jinn-Chyuan Sheu; Bin Guan; Jung-Hye Choi; Athena Lin; Chia-Huei Lee; Yi-Ting Hsiao; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

3.  Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.

Authors:  Yi Liu; Liqun Lv; Wei Xiao; Cheng Gong; Jie Yin; Donghua Wang; Hui Sheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

Review 4.  Molecular mechanisms of cancer development in obesity.

Authors:  Melin J Khandekar; Paul Cohen; Bruce M Spiegelman
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

Review 5.  Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.

Authors:  Nikolaos Spyrou; Konstantinos I Avgerinos; Christos S Mantzoros; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2018-12

6.  Leptin interferes with 3',5'-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells.

Authors:  Qing Lin; Song Ling Poon; Junling Chen; Linan Cheng; Basil HoYuen; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2009-10-22       Impact factor: 5.211

7.  Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.

Authors:  Nikolaos Stefanou; Vassilis Papanikolaou; Yoichi Furukawa; Yusuke Nakamura; Aspasia Tsezou
Journal:  BMC Cancer       Date:  2010-08-19       Impact factor: 4.430

Review 8.  Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.

Authors:  Ayca Gucalp; Neil M Iyengar; Clifford A Hudis; Andrew J Dannenberg
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

9.  Circulating levels of leptin, adiposity and breast cancer risk.

Authors:  M-H Wu; Y-C Chou; W-Y Chou; G-C Hsu; C-H Chu; C-P Yu; J-C Yu; C-A Sun
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

10.  Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.

Authors:  Shahab Uddin; Rong Bu; Maqbool Ahmed; Jehad Abubaker; Fouad Al-Dayel; Prashant Bavi; Khawla S Al-Kuraya
Journal:  Mol Cancer       Date:  2009-09-18       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.